Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of fluocinolone acetonide intravitreal insert in chronic non-infectious uveitis of the posterior segment
2013-001810-14Phase 3Completed
- Sponsor
- EyePoint Pharmaceuticals
- Start
- Aug 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of fluocinolone in uveitis (2 arms), sponsored by EyePoint Pharmaceuticals. Started Aug 2013; status: completed.
02
Drugs
fluocinolone
03
Conditions
uveitis
Beyond the preview
Go deeper on 2013-001810-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001810-14.